News | News By Subject | News by Disease News By Date | Search News

Alopecia (Baldness) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web

Press Releases
Aclaris (ACRS) Submits Investigational New Drug Application For ATI-50002 To Treat Alopecia Areata     8/2/2017
Replicel Life Sciences's Phase I Clinical Trial For Hair Loss Succeeds In Meeting Primary Endpoints     3/14/2017
Perrigo (PRGO) Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine Foam     3/8/2017
Kerastem Completes Enrollment in US Phase II Hair Growth Clinical Trial     9/23/2016
Mallinckrodt (MNK) Completes Acquisition Of Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products     9/1/2016
Mylan (MYL) Launches Generic Propecia Tablets     8/1/2016
Incyte (INCY) Reports 2016 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs     5/9/2016
Concert Pharmaceuticals, Inc. (CNCE) Unveils CTP-543 For Treatment Of Alopecia Areata     5/5/2016
Kerastem Hair Growth Clinical Trial Update     4/22/2016
Samumed Presents At The Annual Meeting Of The American Academy of Dermatology Safety And Efficacy Results From Its Phase 2 Androgenetic Alopecia (AGA) Trial     3/7/2016
Cipher Pharma (DND.TO) Announces Canadian Launch Of Actikerall     2/22/2016
Kerastem's Phase II STYLE Clinical Trial Actively Enrolling Female & Male Subjects with Early Stage Hair Loss     1/21/2016
Samumed Announces Increases In Both Hair Count And Hair Density Observed In Its Phase II Study For A Potential Treatment Of Androgenetic Alopecia (AGA)     12/4/2015
Samumed Completes Phase II Study For Its Potential Treatment Of Androgenetic Alopecia: Safety Data Show No Serious Adverse Events In Any Treated Patient     11/23/2015
Perrigo Company (PRGO) Confirms Filing for Generic Version of Men's Rogaine(R) Foam     10/13/2009